Near-death experiences (NDEs) generally offer accounts of peace, gratitude, and loving encounters with deceased relatives or beings of light. But what happens when, instead of comfort, the experience gives rise to unease, anguish, or even fear?

Music, painting, dreams, death, and coffee came together to enrich the Dreaming and Dying gathering at La Casa Gran del Miracle in Lleida, Catalonia, Spain.

The Medical Association of Lleida, in the Catalonia region of Spain, hosted a lecture by Dr. Luján Comas, President of the ICLOBY Foundation. Local newspapers and television media covered the event.

Sometimes, it is crises that lead us to profound transformation. This testimony is proof that such change is possible when one is able to see the light after darkness has passed through their life.

After surviving a serious car accident, Dr. Zapata began to question everything he had previously learned as a scientist. He had just lived through an experience he could not explain. Where did that vision—what he saw that day and that inexplicably saved his life—ultimately lead him?

More and more scientists and researchers are working to document evidence of life after death. These cases exist, and whether we believe in them or not, what is clear is that they cannot simply be ignored.

Near-death experiences transform the lives of those who go through them and, in most cases, it takes time for individuals to fully accept them. But what happens when the person who experiences it is also a physician actively researching near-death experiences at that very moment?

Trauma, pain, and infections are symptoms that healthcare professionals must address daily in hospitals. In this context, techniques such as clinical hypnosis are proving to be an alternative to the traditional methods that have been used until now.

Organized by ICLOBY Foundation, Barcelona became the meeting place where students of the Master’s Degree in Accompaniment and Grief Support gathered to present their final projects and receive their degrees.

The visit of Dr. Pim van Lommel, director of the Advisory Board of Project LUZ, clarified the roadmap for continuing to strengthen the processes derived from this scientific research, particularly in its follow-up phase.